Cool Website Development

Mobile Version

OfficialLotto

Mayside Research

Tuesday, February 9, 2010

"It's not the sentiments of men which make history but their actions."— Norman Mailer, (1923 - 2007)
SUBMIT PRESS RELEASE
Body Found Dead On Delta Flight
BREAKING NEWS OP-ED BUSINESS SPORT LIFE LEISURE KNOWLEDGE POLITICS GOV44.COM OBITUARIES PRESS RELEASES  
JOURNALIST REGISTRATION LOGIN SIGN UP

Amorfix Life Sciences Ltd. - Pharmaceuticals & Healthcare - Deals And Alliances Profile - New Report Published

Newly released report, Amorfix Life Sciences Ltd. - Pharmaceuticals & Healthcare - Deals and Alliances Profile, provides detailed company analysis

Published on November 24, 2009

by Press Office

(Companiesandmarkets.com and OfficialWire)

LONDON, ENGLAND

Re-Tweet this article
 

Amorfix Life Sciences Ltd. (Amorfix) is an emerging theranostics company focused on the diagnosis and treatment of diseases, where aggregated misfolded proteins (AMP) are prevalent. These include transmissible spongiform encephalopathies (TSE), such as bovine spongiform encephalopathy (BSE) and the human form variant Creutzfeldt-Jakob Disease (vCJD), as well as degenerative diseases, such as Alzheimer's Disease (AD) and Amyotrophic Lateral Sclerosis (ALS) and cancer. Amorfix is developing diagnostic products with a focus on detecting the presence of AMPs in tissue, blood or other biofluids.

Amorfix Life Sciences Ltd. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Summary

Amorfix Life Sciences Ltd. (Amorfix) is a theranostics company engaged in developing therapeutic products and diagnostic devices for treatment of brain-wasting diseases such as Amyotrophic Lateral Sclerosis (ALS), Alzheimer's disease, Parkinson's disease and variant Creutzfeldt - Jakob disease (vCJD). The company intends to develop diagnostic kits, biologic therapeutics, drug therapeutics, and prophylactics, such as vaccines for the treatment of aggregated misfolded proteins (AMP). The company's lead programs include a diagnostic blood screening test for vCJD and a therapy for ALS. The company is headquartered at Mississauga in Ontario, Canada.

The Amorfix Life Sciences Ltd. - Pharmaceuticals & Healthcare - Deals and Alliances Profile is an essential source for company data and information. The profile examines the company's key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy as well as highlighting the company's major recent financial deals.

Scope

- Provides key company information for business intelligence needs
- Gives information on the company's major recent financial deals including Mergers and Acquisitions, asset transactions, PE/VC deals, equity offerings, debt offerings and partnerships.
- Data is supplemented with details on the company's history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement.

Reasons to buy

- A quick "one-stop-shop" to understand the company.
- Support sales activities by understanding your customers' businesses.
- Qualify prospective partners and suppliers.
- Understand and respond to your competitors' business structure, strategy and prospects through.
- Understanding the key deals which have shaped the company.

Amorfix Life Sciences Ltd. - Pharmaceuticals & Healthcare - Deals and Alliances Profile: http://www.companiesandmarkets.com/r.ashx?id=17V2TW137166563

Contact
CompaniesandMarkets.com
Mike King
info@companiesandmarkets.com
Tel: +44 203 086 8600




Posted   11/24/2009 10:34 AM


    
 



Print ArticlePrint EmailEmail Post to DiggPost to Digg
Print ArticleRE-PRINT PERMISSION RSS Local RSS Feed

All form fields are required.

OfficialWire is not storing your Twitter login data!

Mykonos Realty ™ - The Property Experts ™
What would you do with €100 million?

You are here:HomePRESS RELEASES Britain Publishing